Kitano Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• ANCA-associated vasculitis1 trial
• Crohn's disease1 trial
• Heart failure1 trial
• Lupus (SLE)1 trial
• Macular degeneration1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Chiba University1 trial
• Hoffmann-La Roche1 trial
• Juntendo University1 trial

Running trials

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

  NCT06611696· Phase 4· Chiba University· Source

  Contact: Tomomi Endo, MD

• Recruiting

  Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

  NCT05392764· Phase 3· Juntendo University· Source

  Contact: Shinya Ito

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• ANCA-associated vasculitis1 recruiting
• Heart failure1 recruiting
• Lupus (SLE)1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Hoffmann-La Roche· Source